Patent · US Active

Compounds

US8496932B2 · kind B2 · utility

1Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2008
Grant dateJul 30, 2013
Priority date
Expiry dateFeb 18, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to an antibody which has multiple specificities. In particular the antibody of the present invention binds to (cross react with) human IL-8, Gro-alpha, Gro-beta, Gro-gamma, and ENA-78.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.